Bizarre Patents
Self Containing Enclosure for Protection from Killer Bees
A self contained protective enclosure with an opening for entry and egress and a screen for ventilation and viewing.
PatentStorm News
Make the Most of PatentStorm
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest patents by subscribing to an RSS feed.
Got questions? Ask a Patent Expert!
Registered users: Manage your profile, comments and alerts.
US Patent 4444778 - Method and composition for treating atherosclerosis
US Patent Issued on April 24, 1984
Estimated Patent Expiration Date:
August 13, 2002Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
Estimated Patent Expiration Date:
August 13, 2002Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.AbstractA method of improving the arteriosclerotic condition in an animal having arteriosclerosis or having a high risk of developing arteriosclerosis, which method comprises administering an effective amount of a serotonin regulating agent, to inhibit the biological activity of serotonin within the blood vessels, thereby inhibiting the proliferation of smooth muscle cells, which has been found to cause or contribute to an arteriosclerotic condition.Other References
| InventorApplicationNo. 06/407960 filed on 08/13/1982US Classes:514/280, Pentacyclo ring system having the six-membered hetero ring as one of the cyclos514/215, Additional hetero atom in the polycyclo ring system514/288, Ring carbon is shared by three of the cyclos514/324, Ring sulfur in the polycyclo ring system514/325, Polycyclo ring system is tricyclo-carbocyclic514/326, The additional ring is a hetero ring514/419, C=X bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (X is chalcogen)514/654The chain consists of two or more carbons which are unsubtituted or have acyclic hydrocarbyl substituents onlyExaminersPrimary: Schwartz, Richard A.Attorney, Agent or FirmUS Patent References3846476, 3852338, 4224343Process and composition for decreasing blood serum prolactin levelsIssued on: 09/23/1980 Inventor: Wurtman International ClassesA61K 45/06 (20060101)A61K 45/00 (20060101) A61K 31/475 (20060101) A61K 31/495 (20060101) |
